TA
Tamarack Advisers Portfolio holdings
AUM
$2.12M
1-Year Return
56.28%
This Quarter Return
-1.69%
1 Year Return
-56.28%
3 Year Return
-45.76%
5 Year Return
+44.93%
10 Year Return
–
AUM
$169M
AUM Growth
-$2.84M
(-1.6%)
Cap. Flow
-$296K
Cap. Flow
% of AUM
-0.17%
Top 10 Holdings %
Top 10 Hldgs %
52.9%
Holding
52
New
9
Increased
18
Reduced
9
Closed
6
Top Buys
| 1 |
STRM
Streamline Health Solutions
STRM
|
$5.87M |
| 2 |
CVS Health
CVS
|
$4.77M |
| 3 |
Alkermes
ALKS
|
$4.47M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
$3.48M |
| 5 |
Collegium Pharmaceutical
COLL
|
$3.2M |
Top Sells
| 1 |
Cigna
CI
|
$11.9M |
| 2 |
United Therapeutics
UTHR
|
$7.07M |
| 3 |
Labcorp
LH
|
$5.86M |
| 4 |
Amgen
AMGN
|
$5.84M |
| 5 |
Merck
MRK
|
$4.31M |
Sector Composition
| 1 | Healthcare | 96.62% |
| 2 | Consumer Staples | 2.07% |
| 3 | Technology | 1.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Molina Healthcare
MOH
$9.26B
| $1.98M | 1.16% |
+6,000
| New | +$1.98M |
|
27
IQVIA
IQV
$31.3B
| $1.81M | 1.06% |
+10,000
| New | +$1.81M |
|
28
Tactile Systems Technology
TCMD
$299M
| $1.75M | 1.03% |
225,000
+50,000
| +29% | +$390K |
|
29
Plexus
PLXS
$3.72B
| $1.75M | 1.03% |
20,000
+14,000
| +233% | +$1.23M |
|
30
Ascendis Pharma
ASND
$12B
| $1.55M | 0.91% |
15,000
| – | – |
|
31
Fennec Pharmaceuticals
FENC
$255M
| $1.42M | 0.83% |
+175,000
| New | +$1.42M |
|
32
RadNet
RDNT
$5.56B
| $1.22M | 0.72% |
60,000
+10,000
| +20% | +$204K |
|
|
ISEE
33
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $897K | 0.53% |
50,000
-150,000
| -75% | -$2.69M |
|
|
SLGC
34
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $870K | 0.51% |
300,000
-50,000
| -14% | -$145K |
|
35
Bio-Rad Laboratories Class A
BIO
$7.83B
| $834K | 0.49% |
+2,000
| New | +$834K |
|
36
Envista
NVST
$3.45B
| $820K | 0.48% |
+25,000
| New | +$820K |
|
|
DMTK
37
DELISTED
DermTech, Inc. Common Stock
DMTK
| $693K | 0.41% |
175,000
+75,000
| +75% | +$297K |
|
38
MaxCyte
MXCT
$145M
| $534K | 0.31% |
+82,099
| New | +$534K |
|
39
CareDx
CDNA
$697M
| $426K | 0.25% |
25,000
| – | – |
|
|
VRAY
40
DELISTED
ViewRay, Inc.
VRAY
| $364K | 0.21% |
100,000
-300,000
| -75% | -$1.09M |
|
|
SLGCW
41
DELISTED
SomaLogic, Inc. Warrant
SLGCW
| $9K | 0.01% |
20,000
| – | – |
|
42
SPDR S&P 500 ETF Trust
SPY
$662B
| – | – |
0
| – | – |
|
|
43
United Therapeutics
UTHR
$17.2B
| – | – |
-30,000
| Closed | -$7.07M |
|
|
NXGN
44
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| – | – |
-60,000
| Closed | -$1.05M |
|
|
45
Amgen
AMGN
$151B
| – | – |
-24,000
| Closed | -$5.84M |
|
46
Becton Dickinson
BDX
$54.8B
| – | – |
0
| – | – |
|
47
SPDR Gold Trust
GLD
$110B
| – | – |
0
| – | – |
|
48
InMode
INMD
$911M
| – | – |
-50,000
| Closed | -$1.12M |
|
|
49
Labcorp
LH
$22.9B
| – | – |
-29,100
| Closed | -$5.86M |
|
50
iShares S&P 100 ETF
OEF
$22.2B
| – | – |
0
| – | – |
|